Cell Death and Differentiation

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cell Death and Differentiation is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 5,290 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
1476-5403 · 1350-9047
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
5,290 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1998-01-01
  • PUBMED · 2008-02-01
Indexing
MEDLINE · PUBMED
APC
5,290 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
211 days received→accepted — computed from PubMed (n=95)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

5879

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

311

i10-index

4889

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
93%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Cell death & differentiationCDD
Source type
journal
NLM unique ID (PubMed)
9437445
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cell death mechanisms and regulation
  • Cell death mechanisms and regulation
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
Show all subjects (50)
  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • interferon and immune responses
  • interferon and immune responses
  • Phagocytosis and Immune Regulation
  • NF-κB Signaling Pathways
  • NF-κB Signaling Pathways
  • Phagocytosis and Immune Regulation
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • RNA Research and Splicing
  • RNA Research and Splicing
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Inflammasome and immune disorders
  • ATP Synthase and ATPases Research
  • Inflammasome and immune disorders
  • ATP Synthase and ATPases Research
  • Microtubule and mitosis dynamics
  • Microtubule and mitosis dynamics
  • Hippo pathway signaling and YAP/TAZ
  • Hippo pathway signaling and YAP/TAZ
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Immune cells in cancer
  • Immune cells in cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: